Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
Current Oncology · 2023
DOI: 10.3390/curroncol30010055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2023. Verfasst von George Doumat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, American University of Beirut, Beirut 1107-2020, Lebanon. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Antineoplastic Agents, Lung Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung carcinoma (NSCLC) subtype. Despite the increased screening efforts, the median five-year survival of metastatic NSCLC remains low at approximately 3%. Common treatment approaches for NSCLC include surgery, multimodal chemotherapy, and concurrent radio and chemotherapy. NSCLC exhibits high rates of resistance to treatment, driven by its heterogeneity and the plasticity of cancer stem cells (CSCs). Drug repurposing offers a faster and cheaper way to develop new antineoplastic purposes for existing drugs, to help overcome therapy resistance. The decrease in time and funds needed stems from the availability of the pharmacokinetic and pharmacodynamic profiles of the Food and Drug Administration (FDA)-approved drugs to be repurposed. This review provides a synopsis of the drug-repurposing approaches and mechanisms of action of potential candidate drugs used in treating NSCLC, including but not limited to antihypertensives, anti-hyperlipidemics, anti-inflammatory drugs, anti-diabetics, and anti-microbials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, American University of Beirut, Beirut 1107-2020, Lebanon.
- Faculty of Medicine, University of Aleppo, Aleppo 15310, Syria.
- The Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
- Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
ORCID-Profile: George Doumat, Darine Daher, Hisham F Bahmad
Zitieren
APA
Doumat, G., Daher, D., Zerdan, M. B., Nasra, N., Bahmad, H. F., Recine, M., & Poppiti, R. (2023). Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems. Current Oncology. https://doi.org/10.3390/curroncol30010055
Vancouver
Doumat G, Daher D, Zerdan MB, Nasra N, Bahmad HF, Recine M, et al. Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems. Current Oncology. 2023. doi:10.3390/curroncol30010055
BibTeX
@article{Doumat2023,
author = {Doumat, George and Daher, Darine and Zerdan, Morgan Bou and Nasra, Nasri and Bahmad, Hisham F and Recine, Monica and Poppiti, Robert},
title = {Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30010055}
}
EUVIMED